GlassScriptPhysician profile
Jo C Hoffman
NPI 1679930838
$4,507.48
in general payments reported to CMS, 2019-2025
35 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,643 · 2022: $1,677 · 2023: $682 · 2024: $506.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,139 · Education: $49.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,138.54 |
| Education | $49.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $622.69 | 2021-2023 | Xarelto |
| Bayer Healthcare Pharmaceuticals INC. | $521.76 | 2021-2023 | |
| Sanofi-Aventis U.S. LLC | $333.91 | 2021-2023 | |
| Amgen INC. | $326.59 | 2022-2023 | Repatha |
| Pfizer INC. | $311.93 | 2021-2024 | |
| Amarin Pharma, INC. | $310.25 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $236.59 | 2021-2024 | Verquvo, Belsomra, Steglatro |
| Novartis Pharmaceuticals Corporation | $194.19 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $179.75 | 2021-2024 | Jardiance |
| Esperion Therapeutics, INC. | $165.34 | 2021-2024 | Nexletol |
| Novo Nordisk INC | $161.91 | 2022-2023 | Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $126.30 | 2021-2024 | Farxiga |
| Astellas Pharma US INC | $118.68 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $95.21 | 2021-2023 | Evkeeza |
| Vifor Pharma, INC. | $85.59 | 2021 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $80.21 | 2021-2023 | Opsumit |
| Scpharmaceuticals INC. | $76.11 | 2023-2024 | |
| Medtronic, INC. | $71.07 | 2021-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $53.41 | 2024 | Lifevest |
| Tactile Systems Technology INC | $53.06 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $49.45 | 2021 | |
| Baxter Healthcare | $42.56 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Abbvie INC. | $37.29 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $36.45 | 2021-2023 | Eliquis |
| Axsome Therapeutics, INC. | $30.32 | 2023 | Auvelity |
| Edwards Lifesciences Corporation | $28.39 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Abbott Laboratories | $27.91 | 2024 | Thoratec Heartmate 3 Lvas Implant Kit |
| Atricure, INC. | $26.42 | 2022 | |
| Impulse Dynamics (USA) INC. | $19.16 | 2021 | |
| Philips North America LLC | $16.92 | 2022 | |
| Bard Peripheral Vascular, INC. | $15.77 | 2022 | |
| Lilly USA, LLC | $14.50 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $13.18 | 2023 | Arcalyst |
| Kestra Medical Technology Services, INC. | $12.78 | 2022 | |
| Cmp Pharma, INC. | $11.83 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jo Hoffman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.